A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO)

A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO)

Abstract Background Iron deficiency is frequent in haemodialysis (HD) patients with chronic kidney disease (CKD), and intravenous iron is an established therapy for these patients. This study assessed treatment routine, effectiveness, and safety of iron isomaltoside (IIM) 5% (Diafer®) in a HD cohort...

Full description

Bibliographic Details
Main Authors: Ashraf I. Mikhail, Staffan Schön, Sylvia Simon, Christopher Brown, Jörgen B. A. Hegbrant, Gert Jensen, Jason Moore, Lennart D. I. Lundberg
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Nephrology
Subjects:
Chronic kidney disease
Haemodialysis
Iron deficiency
Iron isomaltoside
Haemoglobin
Online Access:http://link.springer.com/article/10.1186/s12882-018-1159-z

Internet

http://link.springer.com/article/10.1186/s12882-018-1159-z

Similar Items